AAAAAA
Results:
1-8
|
Results: 8
Authors:
Alby, F
Mazars, R
de Rycke, J
Guillou, E
Baldin, V
Darbon, JM
Ducommun, B
Citation: F. Alby et al., Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint - Involvement of the CHK2 kinase, FEBS LETTER, 491(3), 2001, pp. 261-265
Authors:
Davezac, N
Baldin, V
Gabrielli, B
Forrest, A
Theis-Febvre, N
Yashida, M
Ducommun, B
Citation: N. Davezac et al., Regulation of CDC25B phosphatases subcellular localization, ONCOGENE, 19(18), 2000, pp. 2179-2185
Authors:
Mils, V
Baldin, V
Goubin, F
Pinta, I
Papin, C
Waye, M
Eychene, A
Ducommun, B
Citation: V. Mils et al., Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase, ONCOGENE, 19(10), 2000, pp. 1257-1265
Authors:
Davezac, N
Ducommun, B
Baldin, V
Citation: N. Davezac et al., Involvment of CDC25 phosphatases in growth control., PATH BIOL, 48(3), 2000, pp. 182-189
Authors:
Escalas, N
Davezac, N
De Rycke, J
Baldin, V
Mazars, R
Ducommun, B
Citation: N. Escalas et al., Study of the cytolethal distending toxin-induced cell cycle arrest in HeLacells: Involvement of the CDC25 phosphatase, EXP CELL RE, 257(1), 2000, pp. 206-212
Authors:
Cans, C
Ducommun, B
Baldin, V
Citation: C. Cans et al., Proteasome-dependent degradation of human CDC25B phosphatase, MOL BIOL RP, 26(1-2), 1999, pp. 53-57
Authors:
Cans, C
Sert, V
De Rycke, J
Baldin, V
Ducommun, B
Citation: C. Cans et al., Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity, ANTICANC R, 19(2A), 1999, pp. 1241-1244
Authors:
Chadebech, P
Brichese, L
Baldin, V
Vidal, S
Valette, A
Citation: P. Chadebech et al., Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage, BIOC BIOP R, 262(3), 1999, pp. 823-827
Risultati:
1-8
|